```html

Quinine Intoxication

Overview

Quinine intoxication (also called quinine poisoning or quinine toxicity) occurs when a person ingests a dose of quinine that exceeds the therapeutic range, producing systemic adverse effects. Quinine is a naturally‑derived alkaloid historically used to treat malaria and, in modern practice, for nocturnal leg cramps, certain cardiac arrhythmias, and as the bittering agent in tonic water.

Although quinine is no longer a first‑line antimalarial in the United States, it is still available in some prescription formulations and over‑the‑counter (OTC) tonic beverages (generally 20‑mg per 12‑oz serving). Intoxication is rare, but when it occurs it can be serious.

• Who it affects: Adults who self‑medicate for leg cramps, patients using quinine for malaria prophylaxis, or individuals who ingest large quantities of tonic water or quinine‑containing supplements.
• Prevalence: According to the U.S. FDA’s Adverse Event Reporting System (FAERS), there were ~1,200 reported quinine‑related adverse events between 2005‑2020, with <5 % classified as severe intoxication. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) recorded an average of 35 hospital admissions per year for quinine toxicity.

Symptoms

Symptoms may appear within minutes to several hours after ingestion and range from mild to life‑threatening. They can be grouped by organ system.

Neurologic

• Headache – often described as a “throbbing” pain.
• Dizziness or vertigo – due to vestibular dysfunction.
• Visual disturbances – blurred vision, photophobia, or transient “seeing stars.”
• Tinnitus – ringing in the ears.
• Seizures – generalized tonic‑clonic seizures are reported in high‑dose exposures.
• Confusion or delirium – may progress to coma in severe cases.

Cardiovascular

• Hypotension – sudden drop in blood pressure.
• Arrhythmias – premature ventricular contractions, QT‑prolongation, or torsades de pointes.
• Bradycardia – slowed heart rate.

Hematologic

• Thrombocytopenia – low platelet count, which can cause easy bruising.
• Agranulocytosis – very low white‑blood‑cell count, increasing infection risk.
• Hemolytic anemia – especially in patients with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency.

Gastrointestinal

• Nausea & vomiting
• Abdominal cramping
• Diarrhea

Renal

• Acute kidney injury (AKI) – manifested by reduced urine output and rising creatinine.

Dermatologic

• Rash – maculopapular or urticarial.
• Pruritus – itching, occasionally with erythema.

Causes and Risk Factors

Primary Causes

• Therapeutic overdose – taking more than the prescribed dose (usually >200 mg in a single dose).
• Accidental ingestion – misreading labels, especially with OTC tonic water or “energy” beverages containing quinine.
• Intentional overdose – rare but reported in suicide attempts.

Risk Factors

• Renal or hepatic impairment – reduced clearance increases plasma levels.
• Elderly patients – decreased metabolism and polypharmacy raise the risk of interactions.
• Concomitant QT‑prolonging drugs – e.g., macrolide antibiotics, fluoroquinolones, anti‑psychotics.
• G6PD deficiency – predisposes to hemolysis.
• Pregnancy – quinine crosses the placenta; clinicians limit use to severe malaria.
• Chronic alcohol use – can potentiate hepatic toxicity.

Diagnosis

Diagnosing quinine intoxication is mainly clinical, supported by laboratory and ECG findings.

History & Physical Examination

• Ask about recent consumption of tonic water, quinine tablets, or “herbal” supplements.
• Assess timing of symptom onset relative to ingestion.
• Examine for signs of bleeding, rash, or neurologic deficits.

Laboratory Tests

• Serum quinine level – measured by high‑performance liquid chromatography (HPLC); >10 µg/mL generally indicates toxicity.
• Complete blood count (CBC) – to detect thrombocytopenia, anemia, or agranulocytosis.
• Electrolytes & renal panel – monitor for AKI and electrolyte disturbances (especially potassium).
• Liver function tests (LFTs) – assess hepatic injury.
• Coagulation profile – prolonged PT/aPTT may signal severe platelet dysfunction.

Cardiac Evaluation

• 12‑lead ECG – look for QTc prolongation (>450 ms in men, >470 ms in women), ventricular ectopy, or conduction blocks.
• Continuous cardiac monitoring in moderate‑to‑severe cases.

Other Tests

• Urine dipstick – for hematuria or myoglobinuria indicating renal damage.
• Peripheral blood smear – may reveal schistocytes in hemolytic anemia.

Treatment Options

Management focuses on supportive care, removing excess quinine, and treating specific complications.

Immediate Measures

• Discontinue quinine exposure immediately.
• Decontamination – If presentation is <2 hours after ingestion and the airway is protected, activated charcoal (1 g/kg) may be administered to limit absorption (per WHO poisoning guidelines).

Supportive Care

• Intravenous fluids – isotonic saline to maintain perfusion and support renal clearance.
• Electrolyte correction – especially potassium and magnesium to reduce arrhythmia risk.
• Antiemetics – ondansetron or metoclopramide for nausea/vomiting.
• Anticonvulsants – benzodiazepines (lorazepam 0.1 mg/kg) for seizures.

Cardiac Management

• IV magnesium sulfate (2 g over 20 min) for QT prolongation or torsades de pointes.
• Continuous telemetry and, if needed, temporary pacing for severe bradyarrhythmias.

Hematologic Interventions

• Platelet transfusion if platelets <20 × 10⁹/L with active bleeding.
• Granulocyte colony‑stimulating factor (G‑CSF) for severe neutropenia.
• Blood transfusion for symptomatic hemolytic anemia.

Renal Support

• Monitor urine output; consider renal replacement therapy (hemodialysis) in refractory AKI or in cases with very high quinine levels (>20 µg/mL), although quinine is only modestly dialyzable.

Pharmacologic Antidotes

There is no specific antidote for quinine. Treatment relies on the measures above and on rapid symptom‑directed care.

Disposition

• Mild cases can be observed in an outpatient setting if vitals are stable and labs are normal.
• Moderate‑to‑severe intoxication warrants admission to a monitored unit or ICU.

Living with Quinine Intoxication

After an acute episode, patients often need ongoing monitoring and lifestyle adjustments.

Follow‑up Care

• Repeat CBC, renal panel, and ECG 48‑72 hours after discharge.
• Consult a hematologist if cytopenias persist beyond two weeks.
• Nephrology referral for persistent AKI or proteinuria.

Medication Review

• Maintain an up‑to‑date list of all prescription, OTC, and supplement products.
• Avoid other QT‑prolonging drugs unless absolutely necessary.

Diet & Lifestyle

• Stay well‑hydrated (2–3 L water/day) to aid renal clearance.
• Limit caffeine and alcohol, which can exacerbate cardiac irritability.
• Consume a balanced diet rich in potassium‑containing foods (bananas, oranges) if labs allow.

Patient Education

• Read medication labels carefully; quinine in tonic water is 20 mg per 12 oz—do not exceed a few servings per day.
• Seek medical advice before using quinine for leg cramps; safer alternatives (e.g., stretching, magnesium supplements) exist.

Prevention

• Prescriber vigilance – Reserve quinine for confirmed malaria or severe conditions, and limit dose to ≤200 mg per day.
• Label clarity – Manufacturers should list quinine content prominently on tonic water packaging.
• Patient counseling – Emphasize that OTC “energy” drinks with quinine are not safe for self‑treating cramps.
• Screen for G6PD deficiency before initiating quinine therapy in high‑risk populations.
• Medication reconciliation during each clinic visit to identify inadvertent duplicate quinine exposure.

Complications

If untreated or inadequately managed, quinine intoxication can lead to:

• Life‑threatening arrhythmias (torsades de pointes, ventricular fibrillation)
• Permanent cardiac conduction defects requiring pacemaker implantation
• Severe hemolytic anemia requiring transfusion
• Irreversible renal failure necessitating long‑term dialysis
• Intracranial hemorrhage secondary to thrombocytopenia
• Neurologic sequelae such as persistent seizures or cognitive deficits

When to Seek Emergency Care

References

• Mayo Clinic. “Quinine (oral route) – Side Effects.” https://www.mayoclinic.org (accessed May 2024).
• U.S. Food and Drug Administration. “Adverse Event Reporting System (FAERS) – Quinine.” 2023.
• World Health Organization. “Guidelines for the Management of Poisonings” (2022).
• Cleveland Clinic. “Quinine Overdose: Symptoms, Diagnosis, and Treatment.” 2024.
• National Institutes of Health, National Library of Medicine. “Quinine Toxicity.” MedlinePlus, updated 2023.
• British National Formulary (BNF). “Quinine – contraindications and drug interactions.” 2024.

```